AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adultsSep 28Weekly roundup, 2 itemsacalabrutinibAstraZeneca
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489
Sign inSign in